The growing threat of the Zika virus urgently needs improved detection methods as vaccine development faces and array of obstacles and is still years off, experts have warned.
The World Health Organization (WHO) fears four million people in the Americas could be infected over the next twelve months and scientists believe the crisis can only be tackled using a multi-pronged approach.
GlobalData’s infectious diseases analyst Mirco Junker said that, while a vaccine could be an effective measure in the long term, it remains several years away and faces numerous obstacles to development.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze